{"certainAgreement":{"otherDetails":"The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"DK0-Disclosure@ferring.com","organization":"Clinical Development Support","title":"Ferring Pharmaceuticals"}}